MARSHALL GR[au] - Search Results

Year	Number of Results
1955	1
1958	1
1964	1
1965	1
1966	2
1967	1
1970	2
1971	2
1972	6
1973	9
1974	8
1975	8
1976	8
1977	4
1978	3
1979	1
1980	1
1981	3
1982	3
1983	6
1984	2
1986	8
1987	9
1988	4
1989	5
1990	9
1991	4
1992	7
1993	9
1994	9
1995	10
1996	6
1997	4
1998	3
1999	4
2000	7
2001	9
2002	5
2003	8
2004	5
2005	8
2006	16
2007	9
2008	9
2009	7
2010	7
2011	5
2012	6
2013	3
2014	4
2015	2
2016	4
2017	6
2018	3
2020	2
2021	1
2022	0

1

Limiting Assumptions in the Design of Peptidomimetics.

Marshall GR, Ballante F. Marshall GR, et al. Drug Dev Res. 2017 Sep;78(6):245-267. doi: 10.1002/ddr.21406. Epub 2017 Sep 6. Drug Dev Res. 2017. PMID: 28875546 Review.

2

Computer-aided drug design.

Marshall GR. Marshall GR. Annu Rev Pharmacol Toxicol. 1987;27:193-213. doi: 10.1146/annurev.pa.27.040187.001205. Annu Rev Pharmacol Toxicol. 1987. PMID: 3555315 Review.

3

Three-dimensional structure-activity relationships.

Marshall GR, Cramer RD 3rd. Marshall GR, et al. Trends Pharmacol Sci. 1988 Aug;9(8):285-9. doi: 10.1016/0165-6147(88)90012-0. Trends Pharmacol Sci. 1988. PMID: 3074545 Review. No abstract available.

4

3D-QSAR: a current perspective.

Green SM, Marshall GR. Green SM, et al. Among authors: marshall gr. Trends Pharmacol Sci. 1995 Sep;16(9):285-91. doi: 10.1016/s0165-6147(00)89052-5. Trends Pharmacol Sci. 1995. PMID: 7482991 Review. No abstract available.

5

Chemogenomics with protein secondary-structure mimetics.

Marshall GR, Kuster DJ, Che Y. Marshall GR, et al. Methods Mol Biol. 2009;575:123-58. doi: 10.1007/978-1-60761-274-2_5. Methods Mol Biol. 2009. PMID: 19727613 Review.

6

Limiting assumptions in structure-based design: binding entropy.

Marshall GR. Marshall GR. J Comput Aided Mol Des. 2012 Jan;26(1):3-8. doi: 10.1007/s10822-011-9494-1. Epub 2012 Jan 3. J Comput Aided Mol Des. 2012. PMID: 22212342 Free PMC article. Review.

7

Back to the future: ribonuclease A.

Marshall GR, Feng JA, Kuster DJ. Marshall GR, et al. Biopolymers. 2008;90(3):259-77. doi: 10.1002/bip.20845. Biopolymers. 2008. PMID: 17868092 Review.

8

Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines.

Nencetti S, Cuffaro D, Nuti E, Ciccone L, Rossello A, Fabbi M, Ballante F, Ortore G, Carbotti G, Campelli F, Banti I, Gangemi R, Marshall GR, Orlandini E. Nencetti S, et al. Among authors: marshall gr. J Enzyme Inhib Med Chem. 2021 Dec;36(1):34-47. doi: 10.1080/14756366.2020.1835883. J Enzyme Inhib Med Chem. 2021. PMID: 33100043 Free PMC article.

9

The biology and future prospects of antivirulence therapies.

Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ. Cegelski L, et al. Among authors: marshall gr. Nat Rev Microbiol. 2008 Jan;6(1):17-27. doi: 10.1038/nrmicro1818. Nat Rev Microbiol. 2008. PMID: 18079741 Free PMC article. Review.

10

Privileged scaffolds targeting reverse-turn and helix recognition.

Che Y, Marshall GR. Che Y, et al. Among authors: marshall gr. Expert Opin Ther Targets. 2008 Jan;12(1):101-14. doi: 10.1517/14728222.12.1.101. Expert Opin Ther Targets. 2008. PMID: 18076374 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results